Johan W. M. Heemskerk

22.0k total citations · 2 hit papers
327 papers, 15.0k citations indexed

About

Johan W. M. Heemskerk is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johan W. M. Heemskerk has authored 327 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Hematology, 74 papers in Cardiology and Cardiovascular Medicine and 73 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johan W. M. Heemskerk's work include Platelet Disorders and Treatments (204 papers), Blood Coagulation and Thrombosis Mechanisms (89 papers) and Antiplatelet Therapy and Cardiovascular Diseases (69 papers). Johan W. M. Heemskerk is often cited by papers focused on Platelet Disorders and Treatments (204 papers), Blood Coagulation and Thrombosis Mechanisms (89 papers) and Antiplatelet Therapy and Cardiovascular Diseases (69 papers). Johan W. M. Heemskerk collaborates with scholars based in Netherlands, Germany and United Kingdom. Johan W. M. Heemskerk's co-authors include Paola E. J. van der Meijden, Judith M.E.M. Cosemans, Marion A.H. Feijge, Marijke J. E. Kuijpers, Theo Lindhout, Edouard M. Bevers, Imke C.A. Munnix, Henri H. Versteeg, Marcel Levi and Pieter H. Reitsma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Johan W. M. Heemskerk

319 papers receiving 14.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Fundamentals in Hemostasis

2013 777 citations Johan W. M. Heemskerk et al. profile →
Platelet biology and functions: new concepts and clinical perspectives

2018 692 citations Paola E. J. van der Meijden, Johan W. M. Heemskerk profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johan W. M. Heemskerk Netherlands	65	7.6k	3.8k	3.4k	2.5k	1.8k	327	15.0k
Barbara C. Furie United States	58	5.9k 0.8×	1.9k 0.5×	4.1k 1.2×	1.6k 0.6×	2.1k 1.2×	156	14.8k
Bernhard Nieswandt Germany	81	11.0k 1.5×	4.8k 1.3×	5.1k 1.5×	2.9k 1.2×	4.3k 2.4×	321	22.9k
Hans Deckmyn Belgium	55	4.3k 0.6×	2.1k 0.5×	1.9k 0.6×	1.2k 0.5×	1.9k 1.1×	291	9.8k
Robert K. Andrews Australia	59	5.4k 0.7×	1.9k 0.5×	2.3k 0.7×	1.3k 0.5×	1.3k 0.7×	190	9.9k
Désiré Collen Belgium	72	6.1k 0.8×	3.1k 0.8×	9.7k 2.8×	4.2k 1.7×	2.1k 1.2×	333	24.7k
David J. Loskutoff United States	77	7.0k 0.9×	1.8k 0.5×	5.3k 1.5×	2.9k 1.1×	2.2k 1.2×	199	19.5k
Meinrad Gawaz Germany	82	6.4k 0.8×	11.6k 3.0×	5.5k 1.6×	2.8k 1.1×	4.2k 2.3×	607	26.7k
Andrew L. Frelinger United States	50	3.2k 0.4×	4.0k 1.0×	1.3k 0.4×	945 0.4×	669 0.4×	170	9.0k
Robert W. Colman United States	66	6.1k 0.8×	1.9k 0.5×	2.7k 0.8×	1.6k 0.6×	2.4k 1.3×	410	14.8k
Eric Jaffe United States	38	3.5k 0.5×	1.8k 0.5×	5.5k 1.6×	1.4k 0.5×	2.5k 1.4×	89	15.6k

Countries citing papers authored by Johan W. M. Heemskerk

Since Specialization

Citations

This map shows the geographic impact of Johan W. M. Heemskerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan W. M. Heemskerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan W. M. Heemskerk more than expected).

Fields of papers citing papers by Johan W. M. Heemskerk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan W. M. Heemskerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan W. M. Heemskerk. The network helps show where Johan W. M. Heemskerk may publish in the future.

Co-authorship network of co-authors of Johan W. M. Heemskerk

This figure shows the co-authorship network connecting the top 25 collaborators of Johan W. M. Heemskerk. A scholar is included among the top collaborators of Johan W. M. Heemskerk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan W. M. Heemskerk. Johan W. M. Heemskerk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thiele, Thomas, Johan W. M. Heemskerk, & Andrew L. Frelinger. (2025). Clinical and research methods for analysis and study of platelet populations. Blood. 146(24). 2889–2901.

Yunga, Samuel Tassi, Paulina B. Szklanna, Özgün Babur, et al.. (2025). Toward standardization and a concerted vision for platelet proteomics research: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 23(5). 1704–1716.

Solari, Fiorella A., Sanne L. N. Brouns, Delia I. Fernández, et al.. (2024). Endothelium‐mediated regulation of platelet activation: Involvement of multiple protein kinases. The FASEB Journal. 38(4). e23468–e23468. 6 indexed citations

Solari, Fiorella A., Nadine J.A. Mattheij, Marijke J. E. Kuijpers, et al.. (2024). Suppressed ORAI1-STIM1-dependent Ca2+ entry by protein kinase C isoforms regulating platelet procoagulant activity. Journal of Biological Chemistry. 300(12). 107899–107899. 3 indexed citations

Fernández, Delia I., Matthias Canault, Anne Krümpel, et al.. (2023). High-throughput microfluidic blood testing to phenotype genetically linked platelet disorders: an aid to diagnosis. Blood Advances. 7(20). 6163–6177. 3 indexed citations

Zhang, Pengyu, Fiorella A. Solari, Johan W. M. Heemskerk, et al.. (2023). Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets. International Journal of Molecular Sciences. 24(9). 7776–7776. 5 indexed citations

Campello, Elena, Joke Konings, Dana Huskens, et al.. (2023). Crucial roles of red blood cells and platelets in whole blood thrombin generation. Blood Advances. 7(21). 6717–6731. 13 indexed citations

Thomas, Patrick, Joana Batista, Carly Kempster, et al.. (2023). A signature of platelet reactivity in CBC scattergrams reveals genetic predictors of thrombotic disease risk. Blood. 142(22). 1895–1908. 5 indexed citations

Brouns, Sanne L. N., Bibian M. E. Tullemans, Cristiana Bulato, et al.. (2022). Protein C or Protein S deficiency associates with paradoxically impaired platelet‐dependent thrombus and fibrin formation under flow. Research and Practice in Thrombosis and Haemostasis. 6(2). e12678–e12678. 4 indexed citations

10.

Jooss, Natalie J., Christopher W. Smith, Alexandre Slater, et al.. (2022). Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation. Journal of Thrombosis and Haemostasis. 20(11). 2617–2631. 20 indexed citations

11.

Perrella, Gina, Samantha J. Montague, Alexandre Slater, et al.. (2022). Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear. International Journal of Molecular Sciences. 23(1). 493–493. 8 indexed citations

12.

Heubel-Moenen, Floor, Sanne L. N. Brouns, Natalie J. Jooss, et al.. (2022). Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time. British Journal of Haematology. 196(6). 1388–1400. 8 indexed citations

13.

Slater, Alexandre, Gina Perrella, Marie-Blanche Onselaer, et al.. (2018). Does fibrin(ogen) bind to monomeric or dimeric GPVI, or not at all?. Platelets. 30(3). 281–289. 32 indexed citations

14.

Whyte, Claire S., Frauke Swieringa, Tom G. Mastenbroek, et al.. (2015). Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow. Blood. 125(16). 2568–2578. 89 indexed citations

15.

Cosemans, Judith M.E.M., Saskia E.M. Schols, Lucia Stefanini, et al.. (2010). Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood. 117(2). 651–660. 55 indexed citations

16.

Munnix, Imke C.A., Karen Gilio, Pia Siljander, et al.. (2008). Collagen‐mimetic peptides mediate flow‐dependent thrombus formation by high‐ or low‐affinity binding of integrin α2β1 and glycoprotein VI. Journal of Thrombosis and Haemostasis. 6(12). 2132–2142. 35 indexed citations

17.

Lievens, Dirk, Alma Zernecke, Linda Beckers, et al.. (2007). Platelet CD40L: a powerful leukocyte and endothelial cell activator in atherosclerosis. Circulation. 116(16). 113–113. 2 indexed citations

18.

Vanschoonbeek, Kristof, Marion A.H. Feijge, Wim H. M. Saris, Moniek P.M. de Maat, & Johan W. M. Heemskerk. (2007). Plasma Triacylglycerol and Coagulation Factor Concentrations Predict the Anticoagulant Effect of Dietary Fish Oil in Overweight Subjects. Journal of Nutrition. 137(1). 7–13. 15 indexed citations

19.

Lecut, Christelle, Anne Schoolmeester, Marijke J. E. Kuijpers, et al.. (2004). Principal Role of Glycoprotein VI in α2β1 and αIIbβ3 Activation During Collagen-Induced Thrombus Formation. Arteriosclerosis Thrombosis and Vascular Biology. 24(9). 1727–1733. 85 indexed citations

20.

Dekker, Els den, Gertie Gorter, Johan W. M. Heemskerk, & Jan‐Willem N. Akkerman. (2002). Development of Platelet Inhibition by cAMP during Megakaryocytopoiesis. Journal of Biological Chemistry. 277(32). 29321–29329. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact